BackInvitae Overview

Invitae Profit Margin

Invitae (NVTA) has a profit margin of -299.14%, below the Healthcare sector average of 13.89%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-777.05%
244.55% YoY

As of Sep 2023

Annual Profit Margin (TTM)

-299.14%
51.57% YoY

Trailing 12 months ending Sep 2023

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Invitae (NVTA) FAQ

Invitae (NVTA) currently reports a profit margin of -299.14% as of September 2023. That compares with -617.65% in the prior-year period — up 51.6% year over year. That is below the Healthcare sector average of 13.89%. Use the charts on this page to explore Invitae's profit margin history and peer comparisons.

Invitae's profit margin increased from -617.65% to -299.14% — a 51.6% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Invitae's profit margin of -299.14% is lower than the Healthcare sector average of 13.89%. That is roughly 2253.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Invitae's current -299.14% should be judged against Healthcare norms (sector average: 13.89%) and against NVTA's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -299.14%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.89%. From there, open related valuation or income-statement pages for Invitae, and consider following NVTA for alerts when major investors trade the stock.